Given the clinical similarities of ChAc and MLS patients, it is likely that abnormal lipid dynamics by the VPS13A–XK partnership lies at the core of the pathogenesis of both diseases. Here, VPS13A is linked to McLeod neuroacanthocytosis syndrome.